Fairvalue-Calculator Fairvalue-Calculator
EN DE

Medartis Holding (MDRSF) Fair Value & Analysis

Healthcare · US · Market cap $1.4B

Price$115.00
Fair Value$17.25
Upside-85.0%
Quality95/100
Evidence: High Range $13.64 – $22.36

Fair value as of: Jun 24, 2026

Analysis

Medartis Holding (MDRSF) currently trades at $115.00, while our model-based Fair Value estimate is $17.25 — implying the stock looks roughly 85.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABTT34) -20% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Medartis Holding (MDRSF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $17.25 versus a price of $115.00 — about −85% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MDRSF?
Our 21-model fair value for Medartis Holding is $17.25 (as of Jun 24, 2026), built from audited fundamentals. The current price is $115.00.
What is the quality score of MDRSF?
Medartis Holding has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.